- Full Year 2024 Astellas Pharma Inc Earnings Presentation TranscriptApr 25, 2024
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 21, 2024
- Q3 2024 Astellas Pharma Inc Earnings Presentation TranscriptFeb 05, 2024
- Astellas Pharma Inc IZERVAY Briefing TranscriptNov 05, 2023
- Q2 2024 Astellas Pharma Inc Earnings Presentation TranscriptNov 01, 2023
- Q1 2024 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2023
- Astellas Pharma Inc to Acquire IVERIC bio Inc M&A Presentation TranscriptMay 01, 2023
- Full Year 2023 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2023
- Astellas Pharma Inc Corporate- wide Digital Transformation Driven by Analytics Briefing TranscriptMar 27, 2023
- Astellas Pharma Inc Sustainability Meeting TranscriptFeb 17, 2023
- Q3 2023 Astellas Pharma Inc Earnings Presentation TranscriptFeb 06, 2023
- Astellas Pharma Inc R&D Briefing TranscriptDec 09, 2022
- Q2 2023 Astellas Pharma Inc Earnings Presentation TranscriptOct 31, 2022
- Astellas Pharma Inc Fezolinetant Briefing TranscriptOct 17, 2022
- Q1 2023 Astellas Pharma Inc Earnings Presentation TranscriptAug 01, 2022
- Full Year 2022 Astellas Pharma Inc Earnings Presentation TranscriptApr 27, 2022
- Astellas Pharma Inc R&D Meeting TranscriptMar 09, 2022
- Astellas Pharma Inc Sustainability Briefing TranscriptFeb 28, 2022
- Q3 2022 Astellas Pharma Inc Earnings Presentation TranscriptFeb 02, 2022
- Astellas Pharma Inc R&D Meeting TranscriptDec 07, 2021
- Q2 2022 Astellas Pharma Inc Earnings Presentation TranscriptOct 29, 2021
- Q1 2022 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2021€13.04 (-10.38%)Earnings
- Astellas Pharma Inc. Corporate Strategic Plan Presentation TranscriptMay 26, 2021
- Full Year 2021 Astellas Pharma Inc Earnings Call TranscriptApr 27, 2021€12.28 (-1.96%)Earnings
- Q3 2021 Astellas Pharma Inc Earnings Call TranscriptJan 29, 2021€13.4 (-1.58%)Earnings
- Astellas Pharma Inc R&D Meeting TranscriptDec 10, 2020
- Q2 2021 Astellas Pharma Inc Earnings Presentation TranscriptOct 30, 2020
- Q1 2021 Astellas Pharma Inc Earnings Call TranscriptAug 04, 2020€13.59 (-0.18%)Earnings
- Full Year 2020 Astellas Pharma Inc Earnings Call TranscriptMay 18, 2020€14.89 (+0.95%)Earnings
- Q3 2020 Astellas Pharma Inc Earnings Call TranscriptJan 31, 2020€16.05 (+2.26%)Earnings
- Astellas Pharma Inc Approaches to Immuno-Oncology R&D Conference Call TranscriptDec 10, 2019
- Astellas Pharma Inc Acquisition of Audentes Therapeutics Inc Call TranscriptDec 03, 2019
- Q2 2020 Astellas Pharma Inc Earnings Call TranscriptOct 31, 2019€15.29 (+1.06%)Earnings
- Astellas Pharma Inc Enfortumab Vedotin Call TranscriptOct 01, 2019
- Q1 2020 Astellas Pharma Inc Earnings Call TranscriptJul 30, 2019€12.34 (-0.80%)Earnings
- Full Year 2019 Astellas Pharma Inc Earnings Call TranscriptApr 25, 2019€11.9 (-0.75%)Earnings
Q1 2022 Astellas Pharma Inc Earnings Call Transcript
Hello, everyone. I'm CSO and CFO at Astellas Pharma Inc. I'm Naoki Okamura. Thank you very much for joining our conference call on our financial results for the first quarter of fiscal year 2021.
As usual, I will give you an overview of financial results and explain our initiatives for sustainable growth. It maybe unusual to say what is not in the script at the beginning. But first of all, we'd like to apologize for the first quarter results, which are not as good as we expected.
So looking at the (inaudible) of the stock market, it reflects the feelings of the investors. So we apologize to the shareholders as well. We are announcing our CSP plan, but we are not complacent. Maybe we were not so careful about what we are doing right now. And so we try to deliver the fiscal year 2021 results. So we'd like to do our best.
Let me move on. Page 2 is a cautionary statement regarding forward-looking information read by (inaudible). So I'd like to skip.
Page 3. Today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)